[1]
|
乔友林, 赵宇倩. 宫颈癌的流行病学现状和预防[J]. 中华妇幼临床医学杂志, 2015, 11(2): 1-6.
|
[2]
|
Linzer, D.I. and Levine, A.J. (1979) Characterization of a 54K Dalton Cellular SV40 Tumor Antigen Present in SV40- Transformed Cells and Uninfected Embryonal Carcinoma Cells. Cell, 17, 43-52.
https://doi.org/10.1016/0092-8674(79)90293-9
|
[3]
|
Levine, A.J., Hu, W. and Feng, Z. (2006) The P53 Pathway: What Questionsremain to Be Explored? Cell Death & Differentiation, 13, 1027-1036. https://doi.org/10.1038/sj.cdd.4401910
|
[4]
|
Vikhanskaya, F., Lee, M.K., Mazzoletti, M., Broggini, M. and Sabapathy, K. (2007) Cancer-Derived p53 Mutants Suppress p53-Target Gene Expression—Potential Mechanism for Gain of Function of Mutant p53. Nucleic Acids Research, 35, 2093-2104. https://doi.org/10.1093/nar/gkm099
|
[5]
|
Levine, A.J., Momand, J. and Finlay, C.A. (1991) The p53 Tu-mour-Suppressor Gene. Nature, 351, 453-456.
https://doi.org/10.1038/351453a0
|
[6]
|
Soussi, T. and Lozano, G. (2005) p53 Mutation Heterogeneity in Cancer. Biochemical and Biophysical Research Communications, 331, 834-842. https://doi.org/10.1016/j.bbrc.2005.03.190
|
[7]
|
邢益详, 谢贞兰, 刘晨. Beclin 1、p53及Ki-67在宫颈病变中表达及临床意义[J]. 慢性病学杂志, 2019, 20(12): 1786-1788.
|
[8]
|
王博, 吉婷, 王林林, 王敏. p53、人半翼基因在宫颈癌前病变及宫颈癌中的表达及相关性分析[J]. 癌症进展, 2021, 19(17): 1801-1804+1811.
|
[9]
|
Lee, Y.-C., Wu, W.-J., Li, W.-M., Lin, H.H., Huang, C.N., Chai, C.Y., et al. (2013) Prognostic Value of p53 Protein Overexpression in Upper Tract Urothelial Carcinomas in Taiwan. Anticancer Research, 33, 1091-1098.
|
[10]
|
赵娟, 胡建生. p16、p53、Ki-67蛋白在宫颈癌组织中表达情况及病理特点分析[J]. 中国妇幼保健, 2019, 34(17): 4080-4082.
|
[11]
|
Malkoc, S., Usumez, S., Nur, M. and Donaghy, C.E. (2005) Reproducibility of Airway Dimensions and Tongue and Hyoid Posi-tions on Lateralcephalograms. American Journal of Orthodontics and Dentofacial Orthopedics, 128, 513- 516. https://doi.org/10.1016/j.ajodo.2005.05.001
|
[12]
|
Paquette, C., Mills, A.M. and Stoler, M.H. (2016) Predictive Value of Cytokeratin 7Immunohistochemistry in Cervical Low-Grade Squamous Intraepithelial Lesion as a Marker for Risk of Progression to a High-Grade Lesion. The American Journal of Surgical Pathology, 40, 236-243. https://doi.org/10.1097/PAS.0000000000000548
|
[13]
|
Chu, P., Wu, E. and Weiss, L.M. (2000) Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases. Modern Pathology, 13, 962-972. https://doi.org/10.1038/modpathol.3880175
|
[14]
|
曹庆营, 李美艳, 牛广旭, 韩新彦. CK7、P16、SCC-Ag对宫颈鳞状上皮内病变的诊断评价[J]. 西部医学, 2021, 33(5): 760-763+770.
|
[15]
|
Lee, H., Lee, H. and Cho, Y.K. (2017) Cytokeratin7 and Cytokeratin19 Expression in High Grade Cervical Intraepithelial Neoplasm and Squamous Cell Carci-noma and Their Possible Association in Cervical Carcinogenesis. Diagnostic Pathology, 12, Article No. 18. https://doi.org/10.1186/s13000-017-0609-4
|
[16]
|
张磊, 蒋冬先, 黄洁, 栾丽娟, 管瑛瑛, 徐磊, 等. 食管鳞状细胞癌中CK7蛋白表达及预后意义[J]. 临床与试验病理学杂志, 2021, 37(7): 814-818.
|
[17]
|
De Lima, T.M., De Azevedo Focchi, G.R., De Almeida, B.C., Belfort-Mattos, P.N., Heinke, T. and De Góis Speck, N.M. (2018) Expression of CK7 and CDKN2 in Cervical Intraepithelial Neoplasia and Correlation with Clinical Outcome. Anticancer Research, 38, 6673-6681. https://doi.org/10.21873/anticanres.13035
|
[18]
|
Mariko, H., Masanori, M., Keita, K., Nakao, Y., Kawaguchi, A., Yokoyama, M., et al. (2019) Decreased Cytokeratin7 Expression Correlates with the Progression of Cervical Squamous Cell Carcinoma and Poor Patient Outcomes. Journal of Obstetrics and Gynaecology Research, 45, 2228-2236. https://doi.org/10.1111/jog.14108
|